Overview Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects Status: NOT_YET_RECRUITING Trial end date: 2024-11-30 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the effects of different dosage regimen on the pharmacokinetics of HRS9531 tablets in healthy subjects.Phase: PHASE1 Details Lead Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.